vs

Side-by-side financial comparison of Kentucky First Federal Bancorp (KFFB) and Roivant Sciences Ltd. (ROIV). Click either name above to swap in a different company.

Kentucky First Federal Bancorp is the larger business by last-quarter revenue ($2.8M vs $2.0M, roughly 1.4× Roivant Sciences Ltd.). Kentucky First Federal Bancorp runs the higher net margin — 10.7% vs -13301.2%, a 13311.9% gap on every dollar of revenue. On growth, Kentucky First Federal Bancorp posted the faster year-over-year revenue change (28.3% vs -77.8%). Kentucky First Federal Bancorp produced more free cash flow last quarter ($-367.0K vs $-201.4M). Over the past eight quarters, Kentucky First Federal Bancorp's revenue compounded faster (24.0% CAGR vs -73.7%).

Kentucky First Federal Bancorp is a U.S. regional bank holding company based in Kentucky. It offers retail and commercial banking services including deposits, mortgage loans, consumer lending and small business financing, serving local individual customers and small-to-medium enterprises across its Kentucky operating regions.

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

KFFB vs ROIV — Head-to-Head

Bigger by revenue
KFFB
KFFB
1.4× larger
KFFB
$2.8M
$2.0M
ROIV
Growing faster (revenue YoY)
KFFB
KFFB
+106.1% gap
KFFB
28.3%
-77.8%
ROIV
Higher net margin
KFFB
KFFB
13311.9% more per $
KFFB
10.7%
-13301.2%
ROIV
More free cash flow
KFFB
KFFB
$201.1M more FCF
KFFB
$-367.0K
$-201.4M
ROIV
Faster 2-yr revenue CAGR
KFFB
KFFB
Annualised
KFFB
24.0%
-73.7%
ROIV

Income Statement — Q2 FY2026 vs Q3 FY2026

Metric
KFFB
KFFB
ROIV
ROIV
Revenue
$2.8M
$2.0M
Net Profit
$304.0K
$-265.9M
Gross Margin
Operating Margin
14.1%
-16966.1%
Net Margin
10.7%
-13301.2%
Revenue YoY
28.3%
-77.8%
Net Profit YoY
2238.5%
-257.0%
EPS (diluted)
$0.04
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KFFB
KFFB
ROIV
ROIV
Q4 25
$2.8M
$2.0M
Q3 25
$2.7M
$1.6M
Q2 25
$2.4M
$2.2M
Q1 25
$2.2M
$-39.6M
Q4 24
$2.2M
$9.0M
Q3 24
$2.0M
$4.5M
Q2 24
$2.0M
$8.0M
Q1 24
$1.8M
$28.9M
Net Profit
KFFB
KFFB
ROIV
ROIV
Q4 25
$304.0K
$-265.9M
Q3 25
$344.0K
$-113.5M
Q2 25
$176.0K
$-223.4M
Q1 25
$7.0K
$-206.5M
Q4 24
$13.0K
$169.4M
Q3 24
$-15.0K
$-230.2M
Q2 24
$-1.1M
$95.3M
Q1 24
$-107.0K
$-151.1M
Operating Margin
KFFB
KFFB
ROIV
ROIV
Q4 25
14.1%
-16966.1%
Q3 25
17.0%
-19492.9%
Q2 25
10.3%
-13130.0%
Q1 25
0.7%
674.8%
Q4 24
0.3%
-3042.6%
Q3 24
-1.0%
-7636.0%
Q2 24
-58.7%
-1279.5%
Q1 24
-7.9%
-919.5%
Net Margin
KFFB
KFFB
ROIV
ROIV
Q4 25
10.7%
-13301.2%
Q3 25
12.9%
-7225.9%
Q2 25
7.6%
-10292.9%
Q1 25
0.3%
521.8%
Q4 24
0.6%
1878.3%
Q3 24
-0.7%
-5143.8%
Q2 24
-56.7%
1192.7%
Q1 24
-5.8%
-522.3%
EPS (diluted)
KFFB
KFFB
ROIV
ROIV
Q4 25
$0.04
$-0.38
Q3 25
$0.04
$-0.17
Q2 25
$0.02
$-0.33
Q1 25
$0.00
$-0.28
Q4 24
$0.00
$0.23
Q3 24
$0.00
$-0.31
Q2 24
$-0.13
$0.12
Q1 24
$-0.01
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KFFB
KFFB
ROIV
ROIV
Cash + ST InvestmentsLiquidity on hand
$19.7M
$4.5B
Total DebtLower is stronger
Stockholders' EquityBook value
$49.1M
$4.3B
Total Assets
$375.3M
$5.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KFFB
KFFB
ROIV
ROIV
Q4 25
$19.7M
$4.5B
Q3 25
$14.6M
$4.4B
Q2 25
$19.5M
$4.5B
Q1 25
$27.8M
$4.9B
Q4 24
$21.0M
$5.1B
Q3 24
$17.3M
$5.4B
Q2 24
$18.3M
$5.7B
Q1 24
$15.4M
$6.5B
Total Debt
KFFB
KFFB
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$311.7M
Q1 24
$430.6M
Stockholders' Equity
KFFB
KFFB
ROIV
ROIV
Q4 25
$49.1M
$4.3B
Q3 25
$48.8M
$4.4B
Q2 25
$48.4M
$4.3B
Q1 25
$48.2M
$4.7B
Q4 24
$48.1M
$5.2B
Q3 24
$48.2M
$5.2B
Q2 24
$48.0M
$5.4B
Q1 24
$49.0M
$6.0B
Total Assets
KFFB
KFFB
ROIV
ROIV
Q4 25
$375.3M
$5.2B
Q3 25
$366.5M
$5.1B
Q2 25
$371.2M
$5.0B
Q1 25
$380.7M
$5.4B
Q4 24
$374.2M
$5.8B
Q3 24
$375.6M
$6.2B
Q2 24
$375.0M
$6.5B
Q1 24
$369.1M
$7.2B
Debt / Equity
KFFB
KFFB
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.06×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KFFB
KFFB
ROIV
ROIV
Operating Cash FlowLast quarter
$-303.0K
$-196.5M
Free Cash FlowOCF − Capex
$-367.0K
$-201.4M
FCF MarginFCF / Revenue
-12.9%
-10076.0%
Capex IntensityCapex / Revenue
2.3%
246.9%
Cash ConversionOCF / Net Profit
-1.00×
TTM Free Cash FlowTrailing 4 quarters
$-377.0K
$-776.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KFFB
KFFB
ROIV
ROIV
Q4 25
$-303.0K
$-196.5M
Q3 25
$450.0K
$-185.7M
Q2 25
$-86.0K
$-204.4M
Q1 25
$-155.0K
$-172.6M
Q4 24
$1.4M
$-207.3M
Q3 24
$-1.4M
$-266.8M
Q2 24
$-1.5M
$-192.8M
Q1 24
$-176.0K
$-108.5M
Free Cash Flow
KFFB
KFFB
ROIV
ROIV
Q4 25
$-367.0K
$-201.4M
Q3 25
$445.0K
$-193.5M
Q2 25
$-235.0K
$-208.4M
Q1 25
$-220.0K
$-173.4M
Q4 24
$1.4M
$-209.1M
Q3 24
$-1.4M
$-267.8M
Q2 24
$-1.5M
$-193.8M
Q1 24
$-191.0K
$-108.8M
FCF Margin
KFFB
KFFB
ROIV
ROIV
Q4 25
-12.9%
-10076.0%
Q3 25
16.7%
-12317.8%
Q2 25
-9.7%
-9604.5%
Q1 25
-9.9%
438.1%
Q4 24
61.8%
-2318.5%
Q3 24
-70.2%
-5984.4%
Q2 24
-77.7%
-2425.5%
Q1 24
-10.4%
-376.1%
Capex Intensity
KFFB
KFFB
ROIV
ROIV
Q4 25
2.3%
246.9%
Q3 25
0.2%
499.6%
Q2 25
6.2%
185.9%
Q1 25
2.9%
-2.0%
Q4 24
3.7%
20.3%
Q3 24
0.1%
22.3%
Q2 24
3.4%
12.1%
Q1 24
0.8%
1.2%
Cash Conversion
KFFB
KFFB
ROIV
ROIV
Q4 25
-1.00×
Q3 25
1.31×
Q2 25
-0.49×
Q1 25
-22.14×
Q4 24
111.31×
-1.22×
Q3 24
Q2 24
-2.02×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons